Aurinia Pharmaceuticals Stock Target Price and Analyst Consensus
| AUPH Stock | USD 8.86 0.01 0.11% |
The current analyst and expert consensus on Aurinia Pharmaceuticals is Strong Buy, with 3 strong buy opinions. The current projected Aurinia Pharmaceuticals target price consensus is 14.00 with 7 analyst opinions. Check out Macroaxis Advice on Aurinia Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more detail on how to invest in Aurinia Stock please use our How to Invest in Aurinia Pharmaceuticals guide.The most common way Aurinia Pharmaceuticals analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Aurinia Pharmaceuticals executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Aurinia Pharmaceuticals. We strongly encourage you to use your own analysis of Aurinia Pharmaceuticals to validate this buy or sell advice. Aurinia Pharmaceuticals buy-or-sell recommendation module provides average expert sentiment on the projected Aurinia Pharmaceuticals target price to derive its highest and lowest estimates based on projected price volatility of 2.6269.
Lowest Forecast 12.74 | Highest Forecast 15.54 | Target Price 14 |
Aurinia |
It's important to approach Aurinia Pharmaceuticals' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Aurinia Pharmaceuticals Target Price Consensus
Aurinia target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Aurinia Pharmaceuticals' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 7 | Strong Buy |
Most Aurinia analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Aurinia stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Aurinia Pharmaceuticals, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationAurinia Pharmaceuticals Target Price Projection
Aurinia Pharmaceuticals' current and average target prices are 8.86 and 14.00, respectively. The current price of Aurinia Pharmaceuticals is the price at which Aurinia Pharmaceuticals is currently trading. On the other hand, Aurinia Pharmaceuticals' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Aurinia Pharmaceuticals Market Quote on 30th of November 2024
Target Price
Analyst Consensus On Aurinia Pharmaceuticals Target Price
Aurinia Pharmaceuticals Analyst Ratings
Aurinia Pharmaceuticals' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Aurinia Pharmaceuticals stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Aurinia Pharmaceuticals' financials, market performance, and future outlook by experienced professionals. Aurinia Pharmaceuticals' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Aurinia Pharmaceuticals price targets
Aurinia Pharmaceuticals' stock target price is an estimate of its future price, usually made by analysts. Using Aurinia Pharmaceuticals' target price to determine if it is a suitable investment can be done through the following steps:- Look at Aurinia Pharmaceuticals' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Aurinia Pharmaceuticals' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Aurinia Pharmaceuticals Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Aurinia Pharmaceuticals is a key component of Aurinia Pharmaceuticals valuation and have some predictive power on the future returns of a Aurinia Pharmaceuticals.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Business Services Invested few shares | |
 | Investor Favorites Invested few shares | |
 | Cash Cows Invested few shares | |
 | Momentum Invested few shares | |
 | Automobiles and Trucks Invested over 50 shares | |
 | Macroaxis Picks Invested over 60 shares | |
 | Macroaxis Index Invested few shares | |
 | Power Assets Invested over 200 shares | |
 | Artificial Intelligence Invested few shares | |
 | Hedge Favorites Invested over 40 shares | |
 | Video Games Invested few shares | |
Check out Macroaxis Advice on Aurinia Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more detail on how to invest in Aurinia Stock please use our How to Invest in Aurinia Pharmaceuticals guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.